Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol plus alfentanil target-controlled infusion versus intermittent bolus for painless gastroenteroscopy
ChiCTR2500104208Phase 4Recruiting
- Sponsor
- Yan'an University Affiliated Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and alfentanil (2 arms), sponsored by Yan'an University Affiliated Hospital. Primary endpoints: Intraoperative incidence of hypoxemia and Intraoperative hypotension. Started Jun 2025; status: recruiting.
02
Drugs
propofolalfentanil
Beyond the preview
Go deeper on ChiCTR2500104208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104208.